Literature DB >> 29715159

Utilization of Hysterectomy Following Chemoradiation for IB2/IIA2 Cervical Cancer in the National Cancer Data Base.

Waqar Haque1, Vivek Verma2, E Brian Butler3, Bin S Teh3.   

Abstract

BACKGROUND/AIM: Performing hysterectomy following chemoradiotherapy (CRT) for IB2/IIA2 cervical cancer is highly controversial. This study evaluated national practice patterns in utilization of post-CRT hysterectomy in the United States compared to CRT alone, as well as outcomes.
MATERIALS AND METHODS: The National Cancer Database was queried for patients with newly diagnosed IB2/IIA2 cervical cancer. Multivariable logistic regression analysis assessing factors predictive of undergoing post-CRT hysterectomy. Kaplan-Meier analysis evaluated overall survival (OS) and Cox proportional hazards modeling determined variables associated with OS.
RESULTS: Altogether, 1,691 patients met the inclusion criteria; 1,551 (92%) received CRT alone, and 140 (8%) underwent subsequent hysterectomy. Patients with tumors ≥8 cm were more likely to undergo hysterectomy. Patients who underwent additional hysterectomy, likely a higher-risk cohort, displayed OS comparable to those receiving CRT alone.
CONCLUSION: Greater tumor size was associated with hysterectomy following CRT for IB2/IIA2 cervical cancer in the United States. These patients achieve OS comparable to those receiving standard-of-care CRT. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Cervical cancer; chemotherapy; hysterectomy; radiation therapy

Mesh:

Year:  2018        PMID: 29715159     DOI: 10.21873/anticanres.12581

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma.

Authors:  Ahmed Khattab; Sunita Patruni; Stephen Abel; Shaakir Hasan; Ethan B Ludmir; Gene Finley; Dulabh Monga; Rodney E Wegner; Vivek Verma
Journal:  J Gastrointest Oncol       Date:  2019-10

2.  Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post radiation surgery.

Authors:  Jie Yang; Jiaxin Yang; Dongyan Cao; Keng Shen; Jiabin Ma; Fuquan Zhang
Journal:  J Gynecol Oncol       Date:  2019-09-17       Impact factor: 4.401

3.  Chemoradiotherapy alone vs. chemoradiotherapy and hysterectomy for locally advanced cervical cancer: A systematic review and updated meta-analysis.

Authors:  Weijia Lu; Canxiong Lu; Zhiwu Yu; Lei Gao
Journal:  Oncol Lett       Date:  2020-12-31       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.